RB1 and psoriasis: Here, for the first time, we observed that IL-17B expression increased in the mesenchymal cells in the skin dermis region, possibly upon TNF-α stimulation during psoriasis, which could subsequently trigger DCs activation and potentially other immune cells via binding to its receptor IL17-RB.